FaibaLite - Reduce Weight, One Bite at a Time
Launched by UNIVERSITY OF BERN · Jun 23, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether chewing a special fiber-enriched gum can help people manage their body weight in a simple and practical way. The idea is that this gum might support healthy weight control by adding fiber to the diet, which can help people feel fuller and potentially reduce overeating.
The study is open to healthy adults between 18 and 65 years old who live in Switzerland and have a body weight that puts their Body Mass Index (BMI) between 23 and 40, which means from slightly overweight to obese. To participate, individuals need to be willing and able to chew the gum three times a day, use an electronic device like a phone or tablet to report their progress, and have a scale to weigh themselves at home. People currently using certain weight loss medications or who have recently changed their smoking habits or medications may not be eligible. This study has not started recruiting yet, but those who join can expect to follow the study routine and share their weight results as the researchers see if the fiber gum helps with weight management.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Written Informed Consent
- • Healthy adults aged 18 to 65 years (inclusive), as determined by the investigator
- • BMI of 23 to 40 kg/m2 (inclusive)
- • Living in Switzerland
- • Ability and willingness to follow the study protocol (e.g., cognitive capacity for compliance, gum chewing)
- • Access and willingness to use an electronic device (e.g., mobile phone, computer or tablet)
- • Access to a scale to self-report weight
- Exclusion Criteria:
- • Current weight loss therapy with Glucagon-like Peptide 1 (GLP-1) agonists or other non-prescription products (at investigator's discretion)
- • Treatment with a GLP-1 agonist within the past 2 months
- • Initiation/Discontinuation of nicotine product use (\>1 nicotine product per day, e.g., (e-)cigarette, gum) within the last 2 months (at investigator's discretion)
- • Significant change in medication within the last 2 months (at investigator's discretion)
- • Unable to chew gum 3 times daily (e.g. due to dental issues, at investigator's discretion)
About University Of Bern
The University of Bern, a leading research institution in Switzerland, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university fosters an environment where scientific inquiry and clinical application intersect. Its commitment to ethical standards and patient safety ensures that all trials are conducted with the highest integrity, striving to contribute valuable insights to the global medical community. The University of Bern actively engages in diverse therapeutic areas, aiming to translate research findings into tangible health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bern, , Switzerland
Patients applied
Trial Officials
Maria L Balmer, Prof. med.
Principal Investigator
Department of Biomedical Research, University of Bern
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported